IN2015DN02999A - - Google Patents

Info

Publication number
IN2015DN02999A
IN2015DN02999A IN2999DEN2015A IN2015DN02999A IN 2015DN02999 A IN2015DN02999 A IN 2015DN02999A IN 2999DEN2015 A IN2999DEN2015 A IN 2999DEN2015A IN 2015DN02999 A IN2015DN02999 A IN 2015DN02999A
Authority
IN
India
Prior art keywords
field
relates
medicine
glucocorticoids
medicament
Prior art date
Application number
Inventor
Michael Aven
Balazs Albrecht
Benjamin Franzmann
Matthias Hausmann
Janine Lamar
Ingo Lang
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of IN2015DN02999A publication Critical patent/IN2015DN02999A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Abstract

The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention relates to a pharmaceutical (medicament) formulation of glucocorticoids, especially ciclesonide or a pharmaceutically acceptable derivative thereof.
IN2999DEN2015 2012-12-21 2013-12-18 IN2015DN02999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12199302 2012-12-21
EP13190393 2013-10-25
PCT/EP2013/077266 WO2014096116A1 (en) 2012-12-21 2013-12-18 Pharmaceutical formulation comprising ciclesonide

Publications (1)

Publication Number Publication Date
IN2015DN02999A true IN2015DN02999A (en) 2015-09-25

Family

ID=49779929

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2999DEN2015 IN2015DN02999A (en) 2012-12-21 2013-12-18

Country Status (10)

Country Link
US (3) US10925964B2 (en)
EP (2) EP2934544B1 (en)
AU (1) AU2013360692B2 (en)
CA (1) CA2888431C (en)
DK (2) DK3473255T3 (en)
ES (2) ES2909039T3 (en)
IN (1) IN2015DN02999A (en)
LT (2) LT3473255T (en)
MX (1) MX364652B (en)
WO (1) WO2014096116A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3473255T (en) 2012-12-21 2022-03-10 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical formulation comprising ciclesonide
BR112015010842B1 (en) 2012-12-21 2021-03-30 Boehringer Ingelheim Vetmedica Gmbh USE OF CYCLESONIDE FOR THE TREATMENT OF RESPIRATORY TRACT DISEASE IN HORSES
DK3157522T3 (en) * 2014-06-18 2019-12-09 Boehringer Ingelheim Vetmedica Gmbh MUSCARIN ANTAGONISTS AND COMBINATIONS THEREOF FOR THE TREATMENT OF HORSE DISEASES
MY194619A (en) 2016-06-02 2022-12-07 Abbvie Inc Glucocorticoid receptor agonist and immunoconjugates thereof
CN111417410B (en) 2017-12-01 2023-06-23 艾伯维公司 Glucocorticoid receptor agonists and immunoconjugates thereof

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954049A (en) * 1991-10-15 1999-09-21 Trudell Medical Limited Equine mask with MDI adapter
DE19536902A1 (en) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Miniature fluid pressure generating device
US5823179A (en) 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US6264923B1 (en) 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10050994A1 (en) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma New diphenylalkanoic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease
DE10062712A1 (en) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma New drug compositions based on anticholinergics and corticosteroids
US6904908B2 (en) 2002-05-21 2005-06-14 Trudell Medical International Visual indicator for an aerosol medication delivery apparatus and system
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
DE10237739A1 (en) 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalable medicament for treating inflammatory or obstructive respiratory diseases, containing synergistic combination of tropane derivative anticholinergic agent, corticosteroid and beta-mimetic agent
WO2004023984A2 (en) 2002-09-13 2004-03-25 Smith C Steven Novel composition and method for treatment of upper respiratory conditions
AU2004241746A1 (en) * 2003-05-22 2004-12-02 Nycomed Gmbh Salmeterol and ciclesonide combination
PL1670482T5 (en) * 2003-09-16 2022-10-03 Covis Pharma Gmbh Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (en) 2003-12-16 2005-11-08 Nycomed Gmbh AQUEOUS CYCLESOUND SUSPENSIONS FOR MISTING
EP1740188A1 (en) * 2004-04-20 2007-01-10 Altana Pharma AG Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
EP1763344A1 (en) * 2004-06-29 2007-03-21 Boehringer Ingelheim International GmbH Medicaments for inhalation comprising steroids and an anticholinergic
DE102004056579A1 (en) 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhaled drugs containing a new anticholinergic, salmeterol and a steroid
UY30543A1 (en) 2006-08-18 2008-03-31 Boehringer Ingelheim Int AEROSOL FORMULATION FOR INHALATION OF BETA- AGONISTS
UY30542A1 (en) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int AEROSOL FORMULATION FOR INHALATION OF BETA AGONISTS
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
NZ596456A (en) 2009-06-25 2014-01-31 Boehringer Ingelheim Vetmed Inhaler
EA201590030A1 (en) 2012-07-05 2015-09-30 Арвен Айлак Санайи Ве Тиджарет А.С. DRY POWDER INHALERS, CONTAINING CARRIER, EXCELLENT FROM LACTOSE, AND THIRD COMPONENT
WO2014007766A1 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhalers comprising a carrier other than lactose
US9539408B2 (en) 2012-10-31 2017-01-10 Trudell Medical International Nebulizer apparatus
LT3473255T (en) 2012-12-21 2022-03-10 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical formulation comprising ciclesonide
BR112015010842B1 (en) 2012-12-21 2021-03-30 Boehringer Ingelheim Vetmedica Gmbh USE OF CYCLESONIDE FOR THE TREATMENT OF RESPIRATORY TRACT DISEASE IN HORSES
PL3035886T3 (en) 2013-08-20 2021-05-31 Boehringer Ingelheim Vetmedica Gmbh Inhaler
EP3035885B1 (en) 2013-08-20 2019-12-25 Boehringer Ingelheim Vetmedica GmbH Inhaler
DK3157522T3 (en) 2014-06-18 2019-12-09 Boehringer Ingelheim Vetmedica Gmbh MUSCARIN ANTAGONISTS AND COMBINATIONS THEREOF FOR THE TREATMENT OF HORSE DISEASES

Also Published As

Publication number Publication date
DK3473255T3 (en) 2022-04-04
US20210106685A1 (en) 2021-04-15
US11819549B2 (en) 2023-11-21
LT2934544T (en) 2019-02-25
EP2934544B1 (en) 2018-11-07
ES2706757T3 (en) 2019-04-01
US20140179650A1 (en) 2014-06-26
EP3473255B1 (en) 2022-01-12
LT3473255T (en) 2022-03-10
US10925964B2 (en) 2021-02-23
US20240024482A1 (en) 2024-01-25
CA2888431C (en) 2021-10-19
DK2934544T3 (en) 2019-03-04
MX364652B (en) 2019-05-03
AU2013360692A1 (en) 2015-04-23
EP2934544A1 (en) 2015-10-28
EP3473255A1 (en) 2019-04-24
ES2909039T3 (en) 2022-05-05
AU2013360692B2 (en) 2018-08-09
MX2015007731A (en) 2015-09-07
WO2014096116A1 (en) 2014-06-26
CA2888431A1 (en) 2014-06-26

Similar Documents

Publication Publication Date Title
TN2015000278A1 (en) Autotaxin inhibitors
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
PH12016500094A1 (en) Autotaxin inhibitors
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
PH12015502002B1 (en) Tripeptide epoxy ketone protease inhibitors
MX2014009757A (en) Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy.
PH12015500713A1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
EP2849770A4 (en) Pharmaceutical compositions for the delivery of substantially water-insoluble drugs
IN2015DN03984A (en)
MY165888A (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
JO3326B1 (en) Tripeptide Epoxy Ketone Protease Inhibitors
HK1211021A1 (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions 2--6--9--9h-
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
IN2015DN02999A (en)
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX2016006544A (en) Withanolides useful for the treatment of neurodegenerative diseases.
IN2013CH04314A (en)
MX366763B (en) PHARMACEUTICAL COMPOSITIONS OF MONTELUKAST and LEVOCETIRIZINE.
UA74882U (en) Pharmaceutical composition for treatment of sexual dysfunction
RU2011145777A (en) MEDICINAL PREPARATION FOR ANTI-INFLAMMATORY ANTI-INFLAMMATORY ACTIVITY